Pharmaceutical CDMO Industry The global pharmaceutical Contract Development and Manufacturing Organization (CDMO) market was valued at approximately USD 146.0 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7.2% from 2024 through 2030. This growth is primarily fueled by rising investments from CDMOs aimed at expanding new drug development capabilities and...